Short description
A biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea.
Description
RespireRx Pharmaceuticals Inc. is focused on developing drug candidates to treat very large respiration related markets that are unserved or poorly served. RespireRx is also developing drugs for niche respiratory markets where premium pricing is probable. All of the Company’s current efforts are involved with sleep apnea/hypopnea, respiratory depression and respiratory distress.
Last funding
No Way
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Glen Rock, New Jersey, United States, North America
Founded on
January 1, 1988
Exited on
November 10, 1989
Went public on
November 10, 1989
Stock symbol
RSPI
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$7890 - 12340
Sign in for full access